Thursday, 13 October 2016

Cardiac Assist Devices Market - Global Industry Analysis and Trends - 2019

In 2012, over 30% of all global deaths could be traced back to cardiovascular diseases (CVDs). An alarming rise in the incidence of CVDs is arguably the biggest factor driving the growth of the global cardiac assist devices (CAD) market, says Transparency Market Research (TMR) in a new report, which is titled, “Cardiac Assist Devices Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013–2019.” The demand for cardiac assist devices will also be helped further by a grave shortage of donor hearts, making heart transplantation only a rare possibility. The report studies the growth prospects in this rapidly emerging market by focusing on specific aspects such as drivers, restraints, challenges, and opportunities. The size of the market is estimated by the demand-based revenue generated via sales of cardiac assist devices.


Patients suffering from cardiovascular diseases are typically advised to consider cardiac assist devices to correct the blood pumping efficiency of the heart. These mechanical pumps work in conjunction with the heart to help an optimum blood flow. The three types of cardiac assist devices (CADs) commonly used are: Intra-aortic balloon pumps (IABPs), ventricular assist devices, and total artificial heart. The ventricular assist devices can either be designed to work with the left or right ventricle. Of these, left ventricular assist devices (LVAD) are the highest sold products and will likely remain popular through the forecast period of the report. With rapid advancements taking place in cardiac assist devices, it is projected that CADs could soon reach a phase where heart transplantation can be entirely avoided. 

The report states that the cardiac assist devices market in North America currently stands as the largest on account of the region reporting a high rate of heart failure cases. Moreover, most new technological developments hit the U.S. first, which makes the uptake of CADs higher in the country as compared to many other markets. The impact of all of these factors is sewn together by the high degree of awareness among patients regarding the benefits of cardiac assist devices and CAD implantation being covered by reimbursement.

Europe trails North America in revenue generation in the cardiac assist devices market. The region reports the second-highest prevalence of cardiovascular diseases among people above the age of 65 years. The report recommends companies in the cardiac assist devices market to also focus on densely populated countries such as China and India where the median age is rising progressively. These countries also present a white space that can be filled in by CADs thanks to a substantial number of underserved cardiac patients. 

Companies that are currently at the forefront of the global cardiac assist devices market are ABIOMED, Inc., Berlin Herat GmbH, Thoratec Corporation, MAQUET GmbH & Co. KG, HeartWare International, Inc. Teleflex Incorporated, and SynCardia Systems, Inc.

Browse Research Report on Global Cardiac Assist Devices Market:
http://www.transparencymarketresearch.com/cardiac-assist-devices.html

Wednesday, 12 October 2016

Ventilator Accessories Market Size, Share and Forecast 2016 - 2024

Ventilators are critical life-support devices that provide respiratory therapy to millions of patients every single day. The ventilator accessories market unveils the characteristics of an increasingly mature market with innovative brands & unique product differentiation in order to secure competitive advantage. The ventilation accessories segment includes flow sensors, breathing sets, expiratory valves, endotracheal tubes, breathing circuits, humidifiers, interfaces, masks & lot more. The relatively inclusive range of end use sectors and specialist applications for innovative ventilator accessories represents a supportive factor in terms of the long term market growth. Large medical device manufacturers are majorly focused on launching novel products in order to accomplish development in the global ventilators market. Companies are also more attentive on collaboration by acquiring domestic and international players to expand their product portfolios and boost their distribution channels in emerging markets. High-tech advancement is another key factor for manufacturers to improve technologies and thus prevent respiratory illness and reduce the time spent on other ventilation procedures.


Drivers & Restraints

Rising elderly population, growing prevalence of respiratory disorders, and rising number of preterm births are predictable to fuel the growth of ventilators accessories market in the forecast period. Ventilator accessories market growth has been driven by increasing in sales of portable and mechanical ventilators. Furthermore there is also an increase in the relevance of hospitals, medical emergency services and rehabilitation centers can be expected to rise in the demand for ventilators. Industry experts design these accessories utilizing the high grade standard material with high-end technology. Manufacturers are mainly focused for the highest possible patient safety and ease of use. Growing per capita income, extensive R&D investments in the healthcare industry by top market players, rising demand for advanced front-line technologies, and expansion of private hospitals and rehab-centers in remote areas are the major factors driving growth of the ventilators accessories market globally. Also, lack of access to primary care in developing regions is comparatively driving sensitive demand for urgent respiratory care utilization. Patient safety and operator control safety is the prime concern which has been regulated by the few official authorities which has executed huge challenges for the medical device manufacturers. New materials may bring together biocompatibility and circuitry issues.

Global Ventilators Market: Segmentation

The Global Ventilators Market market can be segmented as follows:

Global ventilator accessories market by Product Type
  • Flow sensors
  • Breathing sets
  • Expiratory valves
  • Endotracheal tubes
  • Breathing circuits
  • Humidifiers
  • Interfaces and masks
  • Others
Global Ventilators Market, by End User
  • Hospitals
  • Ambulatory Surgery Centres
  • Clinics
  • Emergency Medical Services
  • Long term care centres 
  • Global Market: Regional Outlook
Geographically, the global ventilator accessories market is segmented into five regions, namely North America, Latin America, Europe, Asia Pacific & the Middle East and Africa (MEA). North America (U.S) is the largest regional segment of the overall ventilator market, followed by Europe region. Currently Asia-Pacific region has also enhanced the growth rate during the forecast period. The rate of efficiency is mainly attributed to the geriatric population worldwide, rising incidences of cardio-vascular & respiratory diseases, extensive growth in healthcare expenditure, and rapidly growing healthcare industry worldwide. These regions are expected to generate the fastest growth rates potentially.

Global Ventilators Market: Key Players

The key players in the Ventilators market are
  • Drägerwerk AG & Co. KGaA
  • GE Healthcare Ltd.
  • Siemens Healthcare
  • ResMed Inc.
  • Fisher & Paykel Healthcare Corp. Ltd.
  • Hamilton Medical AG
  • Invacare Corp.
  • CAS Medical Systems Inc.
  • Nihon Kohden Corp.
  • Nonin Medical Inc.
  • Criticare Systems Inc.
  • Spacelabs Healthcare Inc.
  • Nellcor Puritan Bennett LLC
  • ALARIS Medical Systems Inc.
  • Criticare Systems Inc.
  • Masimo Corp.
  • Welch Allyn Inc.
The global market for ventilator accessories market is further expected to witness significant growth over the report’s forecast period owing to the rapid and consistent technological innovation in these medical devices and the rising cases of chronic respiratory disorders among people worldwide.

Browse Research Report on Global Ventilator Accessories Market:
http://www.transparencymarketresearch.com/ventilator-accessories-market.html

Monday, 10 October 2016

Single Port Surgical Platform Market Global Industry Trends and Forecast 2024

Single port surgical platform (SPSP) is a minimal invasive laparoscopy technique in which, a single incision is made on the body through single trocar which have multiple ports or single skin incision site with multiple facial incisions that have an individual trocar, are used to conduct the surgery. Single port surgical platforms are also called Single Port Access Surgery (SPA), Single-Incision Laparoscopic Surgery (SILS), and Laparo-endoscopic Single-Site Surgery (LESS). Normally, in abdominal surgeries, large incisions are made to conduct the surgery. Although, they are effective but they usually cause postoperative pain, wound infections, and prolonged hospitalization. Current rate of incisional hernia is 4-18% and wound infections are 2-25% in the U.S whereas, in case of conventional laparoscopic surgeries, multiple incisions are made on the body to conduct the surgery. To overcome the above challenges, companies are focusing on developing the novel single-port surgical platform, which creates single incision on the body. This surgical platform also helps in speedy recovery, small incisions, and are less prone to infections and pain conditions. In addition to these, it does not leave any scars on the body after the surgery.


The market is driven mainly by factors such as technological innovations, increase in adoption of SPSP, growing preference towards minimally invasive surgery process, and exploration of their utility in other applications Ex: General Surgery, Gastroenterology, Urology, Gynecology and Bariatric Surgery. Increasing preference towards scar-less slimming surgeries is a major factor responsible for boosting the market growth. This platform allows surgeons to conduct surgeries in the abdominal cavity by accessing through small holes. Furthermore, SPSP reduces treatment costs by reducing hospital stay of the patients. Hence, patients and surgeons are prefer SPSP as compared to others. The major constraints of this market are high cost, lack of skilled professionals, and triangulation problems. The single port surgical platform (SPSP) is segmented based on its application and technology.

Segmentation by Application
  • General Surgery
  • Gastroenterology
  • Urological
  • Gynecological
  • Bariatric
Segmentation by Technology
  • Robot/ Remote controlled Assisted
  • Manual – Assisted
New products are being launched into the market to alleviate the disadvantages of the current SPSP platforms. SPSP is a lucrative segment in the laparoscopic surgeries, due to its technical aspects and patient benefits. On the basis of application, SPSP is mainly used in Bariatric surgeries. However, they are gaining traction of the other application areas such as gynecology, urology, gastroenterology, and general surgery due to its advantages.

On the basis of its technology, the manual assisted SPSP holds major market share as compared to robot-assisted. In future, robot/ remote controlled technology is expected to dominate the market because surgeons can perform the complex surgeries in a more accurate and flexible way than the conventional surgery process by using the robot/ remote controlled technology
Recently, Intuitive surgical, a U.S.-based company, received FDA approval for its da Vinci Sp single port robot-assisted surgical system.

SPSP is segmented into North America, Europe, Asia-Pacific, Latin America and Middle East & Africa. North America is holds a major market share on the basis of application of the SPSP owing to factors such as spending power of the people and introduction of new technologies into the market. Asia-Pacific markets are growing relatively fast due to cost effective surgeries and advancements in healthcare infrastructure.

Key players in this market are Covidien, Applied Medical, Ethicon, Olympus Gyrus-ACMI, Novare Surgical, Cambridge Endo, Karl Storz, Intutive surgical, Fortmedix Surgical, and Trans Enterix. The market is relatively dominated by major players however, new players are trying to hold a major part of the market share by developing innovative products.

Browse Research Report on Global Single Port Surgical Platform Market:
http://www.transparencymarketresearch.com/single-port-surgical-platform-market.html

Friday, 7 October 2016

Glenoid Implant System Market Trends and Global Industry Share Up to 2024

Glenoid implants are mainly used for hemiarthroplasty. Hemiarthroplasty involves replacing just the joint surface of the humeral head with a cap-like prosthesis without a stem. In shoulder replacement surgery, the damaged parts of the shoulder are removed and replaced with artificial components, called a prosthesis. The treatment options are either replacement of just the head of the humerus bone (ball), or replacement of both the ball and the socket called Glenoid. Implanting the glenoid in a proper orientation is essential for long-term stability of the prosthesis. A malpositioned glenoid may have compromised fixation due to inadequate bony support or incomplete implant seating and may be subjected to increased torques on the fixation surface. The other causes for Glenoid implants are Osteoarthritis, Rheumatoid Arthritis, degenerative arthritis, Rotator Cuff Tear Arthroplasty, Avascular Necrosis, and Severe Fractures etc. According to the Agency for Healthcare Research and Quality, about 53,000 people in the U.S. have shoulder replacement surgery each year. Implantation of a glenoid component is not advised if the glenoid has good cartilage, the glenoid bone is severely deficient, and the rotator cuff tendons are irreparably torn. Glenoid Implants are available in different size, such as small, medium, large and XL. Glenoid involvement in degenerative arthritis varies depends on the type of arthritic process affecting the glenohumeral. For Instance, inflammatory arthritis is associated with central glenoid erosion. The extent and location of glenoid wear should be assessed preoperatively with axillary radiographs, axial CT scans and through the glenohumeral joint, or 3D CT reconstructions.


Achieving long-term fixation of the glenoid is a primary goal in total shoulder arthroplasty. Several methods of fixation have been attempted, including cemented, noncemented, and hybrid or minimally cemented devices. Cemented pegged and keeled components are used most commonly and are provide the most predictable fixation. Noncemented glenoids rely upon mechanical interlock and biologic integration, typically by screw fixation or a combination of screw or press-fit pegs, or both, to achieve an initial fixation that facilitates long-term bone in-growth/on-growth. According to center of disease control and prevention the prevalence of diagnosed arthritis is expected to increase among US population in the coming decades. By the year 2040, an estimated 78 million adults aged 18 years and older will have diagnosed with arthritis, compared with the 52.5 million adults in 2010-2012.

Glenoid Implant System Market: Drivers and Restraints

Factors such as Growing prevalence of symptomatic shoulder arthritis, increased patient awareness, technological advancement and expanded medical education and surgeon adoption of total shoulder replacement will fuel the overall glenoid implant market globally. According to National Health Interview Survey, 22.7 million (9.8% of all adults) have arthritis and arthritis-attributable activity limitation. Factors such as glenoid component loosening, pricing pressure, improper handling of implants are the factors will hinder the total glenoid implant market globally. Glenoid loosening is associated with increased pain, decreased shoulder function, and the need for revision surgery. 

Glenoid Implant Systems Market: Segmentation

The global Glenoid implant systems market is classified on the basis of product type, Size, end user and regional presence.

Segmentation based on product type:
  • Pegged Glenoids
  • Keeled Glenoids
Segmentation based on Size:
  • Small
  • Medium
  • Large
  • XL
Segmentation based on end user:
  • Hospitals
  • Clinics
  • Orthopedic Surgery Centers
Glenoid Implant Systems Market: Regional Overview

Geographically, the global glenoid implant systems market is classified into regions namely, North America, Latin America, Western Europe, Eastern Europe, Asia-Pacific, Japan, Middle East and Africa. North America dominates the glenoid implant systems market due to rising obese population. North America is followed by Europe and Asia Pacific. Asia Pacific is expected to grow at a highest rate due to fast disease progression, higher prevalence, improving healthcare infrastructure, economic growth, broadening insurance coverage, expanding private healthcare sector, and increasing awareness amongst people. Glenoid Implant device markets experienced a slowdown in 2012 in Japan, caused by reimbursement protocols instituted by the Japanese government.

Glenoid implant Systems Market: Key Players

Some of the major players operating in the market for global Glenoid implant are Smith & Nephew, Stryker, Zimmer, Tornier, Inc., Biomet, Exactech, Lima Corporate, Arthrex, Inc., Integra LifeSciences, DePuy Synthes, while there are a range of other smaller players as well. DePuy Synthes and Tornier represent more than half of the total market size due to its most diversified and innovated portfolios. DePuy and Tornier are expected to be the leading players in the arena for another five years

The report covers exhaustive analysis on:
  • Market Segments
  • Market Dynamics
  • Market Size
  • Supply & Demand
  • Current Trends/Issues/Challenges
  • Competition & Companies involved
  • Technology
  • Value Chain
Regional analysis includes
  • North America (U.S., Canada)
  • Latin America (Mexico, Brazil)
  • Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
  • Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
  • Asia Pacific Excluding Japan (China, India, ASEAN, Australia & New Zealand)
  • Japan
  • Middle East and Africa (GCC, S. Africa, N. Africa, Rest Of MEA)
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.

Browse Research Report on Global Glenoid Implant System Market:
http://www.transparencymarketresearch.com/glenoid-implant-system-market.html

Thursday, 6 October 2016

Telemonitoring Systems Market Can Transform Quality of Home Healthcare

Healthcare monitoring systems have been an integral part of the patient care services since a very long time. They are used to observe the symptoms, condition and other medical parameters of the patient. It is performed by measuring the vital medical parameters of the patient such as the heart rate, blood pressure, blood sugar level, etc. Telemonitoring systems are the medical devices used for the remote diagnosis, examination and monitoring of the patients by the clinicians. 


Telemonitoring systems allow the physicians and doctors to monitor the patient’s vital statistics at any given time. The rapid advancements in the information and visualization technology have provided new opportunities in the telemonitoring systems market. The telemonitoring systems enable the healthcare providers to provide effective and timely medical aid to the patients before it turns into a bigger problem. The data collected through monitoring must be analyzed thoroughly for suitable treatment measures. People who do not have access to high end hospital care due to lack of proper transportation or are unable to visit the doctor frequently due to critical conditions, telemonitoring systems have facilitated them to gain access to enhanced healthcare facilities, thus reducing the morbidity  and mortality rates. Telemonitoring systems are used for the management a variety of disorders. For example, patients with heart ailments can have their blood pressure and weight monitored on a daily basis. Any undesirable sudden change in the blood pressure/flow or weight can reflect a need to attend the possible worsening condition. If diagnosed on time, the treatment is more likely to be easily managed and the chances of hospitalizations are reduced. Diabetic patients can measure their blood glucose levels regularly and sustain these levels within a healthy range.  

The telemonitoring systems market is mainly driven by the incidence and prevalence rate of diseases such cardiovascular disease, chronic obstructive pulmonary disease (COPD), diabetes, etc. Moreover the demand of better measures for remote monitoring of patients and integration of information technology and monitoring devices have also propelled the market for telemonitoring systems. This integration has benefitted the patients with adequate monitoring at the comfort of home and are reducing the number of hospitalization and hence promoting efficient healthcare at home. High pool of geriatric population is also the major driver for the telemonitoring systems market.

The Global Telemonitoring Systems market is segmented on the basis of product type, end-user and regional presence:

Segmentation based on product type
  • COPD  Telemonitoring System
  • Glucose Level Telemonitoring System
  • Blood Pressure Telemonitoring System
  • Cardiac Telemonitoring System
  • Others 
Segmentation based on End-user
  • Home Care
  • Long-term Care Centers
  • Hospice Care 
With the growing geriatric population leading to increase in the various disease indications, the telemonitoring systems market is also expected to increase rapidly. Moreover substantial rise in the healthcare spending and upsurge in disposable income will boost the telemonitoring systems market during the forecast period.

Geographically the telemonitoring systems market is segmented into five key regions: North America, Latin America, Europe, Asia Pacific and MEA region.

North America is anticipated to be the largest market for telemonitoring systems. The demand for telemonitoring systems market in the U.S. is driven by the country’s strong economy and the rising trend of home nursing facilities and hospice care. Other factors attributable to market growth include increasing patient awareness, technological innovations, high investments in research and development, and the increasing disease incidences. The telemonitoring systems market is also expected to witness strong growth in Europe due to advantages such as accurate diagnosis with easy to use technology and ease in data sharing. Asia-Pacific is also expected to be the promising market for AVS technology in the near future due to developing economies and presence of large under-served patient population. Latin America also offers immense growth potential in the near future due to extensive development of health care infrastructures, increasing population, and rising government funding. However, high costs for set-up and maintenance can be a major restraint of the market in regions such as Middle East & Africa.

Some major companies in the telemonitoring systems market are Abbott, Cisco Systems, Inc., DigiO2 International Co. Ltd., GE Healthcare, Honeywell HomeMed, Mindray Medical International Limited, Philips Healthcare, Qi Imaging, LLC, Siemens Healthcare, and Telehealth Solutions.

Browse Research Report on Global Telemonitoring Systems Market:
http://www.transparencymarketresearch.com/telemonitoring-systems-market.html

Wednesday, 5 October 2016

Single-use Bioreactors Market Global Analysis in Pharmaceutical Industry in 2019

A new market intelligence study by Transparency Market Research offers a thorough overview of the global single-use bioreactors market. The research study, titled “Single-use Bioreactors Market - Global Industry Analysis, Size, Share, Growth, Trends and Forecast, 2013–2019,” presents insights into the key growth prospects, latest trends, and opportunities in the market. The historical data, past performance, and expected growth rate and statistics have been included in the research study to offer a clear picture of the market. 


Single-use bioreactors have been gaining traction in recent years as they offer several benefits over conventional bioreactors. Single-use bioreactors ensure safety and do not require any kind of sterilization or cleaning. Moreover, these bioreactors help in saving time and operational cost, thus augmenting the growth of the market. Key types of single-use bioreactors include non-stirred disposable bioreactors, stirred flexible disposable bioreactors, stirred rigid disposable bioreactors, and non-stirred flexible bioreactors. The rising number of diseases across the globe and increasing demand for drugs to treat the patients is the primary factors estimated to boost the demand for single-use bioreactors in the forecast period. 

Ease in the cultivation of marine organisms and reduced complexity of automation are the primary factors driving the global single-use bioreactors market. In addition, the increasing popularity of subs among several biopharmaceutical companies and swift growth of the biologics market are expected to create new opportunities in the global market. However, several regulatory issues related to single-use bioreactor and concerns associated with extractables and leachables are projected to restrict the growth of the global single-use bioreactor market in the coming years.

On the basis of geography, the global single-use bioreactors market can be classified into North America, Europe, Asia Pacific, and Rest of the World. Among these segments, Europe and North America account for a massive share in the global market at present as most of the prominent biopharmaceutical companies are located in these two regions. On the other hand, Asia Pacific is projected to witness significant growth in the next few years as several leading companies are setting up their manufacturing units in this region and driving the demand for disposable bioreactors.

Key players operating in the global market for single-use bioreactors include Merck Millipore, PBS Biotech, GE Healthcare, Xcellerex, Cellexus Limited, Sartorius Stedim Biotech, and Thermo Fisher Hyclone. The improved returns on investment for startups and small companies are expected to encourage the participation of new entrants and fuel the growth of the overall market in the next few years.

Browse Research Report on Single-use Bioreactors Market:
http://www.transparencymarketresearch.com/single-use-bioreactors-market.html

Monday, 3 October 2016

Wound Dressings Market: Advanced Wound Dressing Boosted by Increasing Healthcare Expenditure

The global wound dressings market is highly fragmented in nature due to the stakes of numerous global and regional players in the industry. The top three players in the market accounted for approximately 52% of the overall market value in 2013, finds Transparency Market Research (TMR) in a new study. These three players are Smith & Nephew plc, Mölnlycke Health Care, and ConvaTec Inc. 

“Efficient distribution networks, product differentiation, and supply competency play a central role in determining the market position of players. Companies are engaging in mergers and acquisitions to gain a competitive edge over others in this highly competitive marketplace,” says the author of the report.

The global wound dressings market was valued at US$8.11 bn in 2015 and is poised to reach US$10 bn by 2020, rising at a CAGR of 4.5% from 2014 to 2020. Traditional wound dressings will continue to dominate the market in terms of revenue until 2020. However, due to rising awareness about the benefits, the advanced wound dressings segment is expected to expand at a significant CAGR of 7.6% over the forecast period.


Asia Pacific to Emerge as Significant Market for Wound Dressings Manufacturers

The global wound dressings market is broadly classified into traditional wound dressings and advanced wound dressings. Asia Pacific will continue to be the leading traditional wound dressings market until 2020, representing nearly 32% of the global market value. However, Rest of the World will expand at an impressive CAGR during the same period. On the other hand, North America will continue to dominate the advanced wound dressings market by revenue until 2020. Due to rising per capita expenditure on healthcare and improving economic conditions, Asia Pacific will rise at a CAGR of 9.3% between 2014 and 2020.

Rising Geriatric Population to Augment Growth of Wound Dressings Market

The rise in geriatric population can potentially increase the demand for medical services three to five folds and trigger the prevalence of non-communicable diseases. This factor boosts the need for surgical procedures, consequently propelling the growth of the global wound dressings market. Moreover, the rise in life expectancy of the population worldwide is increasing the demand for healthcare. This, in turn, is fuelling the demand for wound care dressings.

“New product development and novel therapies are helping reduce wound-related infections among patients while also cutting down on healing time. These benefits are conducive to the greater uptake of advanced wound dressings,” says a TMR analyst. Improvements in synthetic dressing materials, recombinant factors, endovascular techniques, and bi-layered human dermal substitutes are positively influencing the growth of the global market. Other factors driving the market are the rising incidence of chronic diseases and wound infections, increasing per capita spending on healthcare, and growing patient awareness regarding personal health.

Reluctance in Adoption of Novel Therapies to Impede Revenue Growth of Wound Dressings Market

The advanced wound dressings are only affordable amongst the affluent population. Asian markets being price sensitive have significant inhibitions on investing in advanced wound care. This limits the adoption of the advanced wound dressings. Moreover, reluctance in adoption of novel wound care technologies amongst healthcare providers and physicians, especially in Europe and Asia, is stagnating the sales of advanced technologies. Furthermore, the absence of a favorable reimbursement scenario is hampering the wide-scale adoption of wound care dressings. These factors, collectively, are restraining the growth of the global wound dressings market. However, manufacturers are increasingly focusing on the development of combination dressings to strike a balance between cost and functionality. In the foreseeable future, this factor is likely to augur well for the growth of the market.

Browse Research Report on Global Wound Dressings Market:
http://www.transparencymarketresearch.com/wound-dressing-market.html